Trial Profile
A single center, retropsective study of imatinib in gastrointestinal stromal tumors (GISTs) of the small intestine
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Nov 2016
Price :
$35
*
At a glance
- Drugs Imatinib (Primary)
- Indications Gastrointestinal stromal tumours
- Focus Therapeutic Use
- 14 Nov 2016 New trial record